Clinical Trial: Phase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers:

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07488247) titled 'Phase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers:' on March 11.

Brief Summary: Protocol No. CHLORIN E6-IIB/III-01/Protocol/1.1 Study Title Single-Centre, open-labeled, randomized, Phase IIb and Phase III clinical studies to evaluate the safety, tolerability, and efficacy of Chlorin E6 (Gel Formation) as a photosensitizing agent for the management of Diabetic Foot Ulcers with Photodynamic Therapy.

Version No. 1.1 Version Date 01-Aug-2024 Sponsor Synverdis GmbH, Heidelberg, Germany. Study Phase Phase IIb & Phase III Indication : Diabetic Foot Ulcers Study Population This study ...